Introduction {#sec1-1}
============

Pulmonary anthracosis is characterized by the formation of black nodules in bronchial mucosa (Touhidi et al., 2002). Repeated exposure to carbon, silica or quartz dust (as in workplaces) may cause pulmonary anthracosis; however, cases with no history of occupational exposure have also been reported (Naeye, 1994). Anthracosis can be diagnosed by bronchoscopy. In some cases, anthracosis may progress and cause bronchial obstruction (Chung et al., 1998). Anthracosis may damage the bronchial mucosa and impair mucociliary clearance of the bronchi; this can predispose patients to pulmonary infection (Sonnenberg et al., 2000; Castranova et al., 2002). Also, some studies have shown an association between anthracosis and development of lung cancer (Hou et al., 1998), 17. Lung cancer has high rate of morbidity and mortality. Treatment of lung cancer is challenging because effective treatment strategies and specific markers for early detection of lung cancer do not exist (Cheng et al., 2008; Ghadimi et al., 2017; Karimi et al., 2017; Moshref et al., 2017). Several tumor markers have been tested for diagnosis and prognosis of lung cancer such as CEA, CK19, VEGF and LUNX (Wieskopf et al., 1995; Iwao et al., 2001; Lantuéjoul et al., 2003; Snead et al., 2003; Chanin et al., 2004; Wallace et al., 2005; Karimi et al., 2015). Lung cancers are divided into two types of small cell lung cancer and NSCLC; NSCLC is the most important and most common form of lung cancer. It is an epithelial tumor, which may metastasize at initial stages and expand (Wieskopf et al., 1995; Iwao et al., 2001).

P16 as tumor suppressor impedes tumor growth by inhibiting cell cycle (Pisani et al., 1997). Expression of P16 regularly occurs in old cells and increases with age (Collado et al., 2007). Activation of P16 prevents the occurrence of cancer by stopping cell growth(Esteller et al., 2001). Inactivation of P16 by its elimination, point mutation or methylation of its promoter results in out of control cell proliferation, which eventually results in cancer. Methylation of P16 promoter and turn-off of this gene has been reported in many cancers (Esteller et al., 2001; Payá et al., 2009). In addition, the CDH1 (E-cadherin) is a member of the cadherin family and is among the most important molecules enabling cell attachment (Hulpiau and Van Roy, 2009). It is capable of inhibiting metastasis and invasion of cancer cells(Hulpiau and Van Roy, 2009). Most cancer cells in human tissues relatively or completely lose their E-cadherin molecules as they progress towards malignancy (Sundfeldt, 2003; Strumane et al., 2004; Naora and Montell, 2005). Significant reduction in expression of E-cadherin has been reported on the surface of cancer cells (Kleer et al., 2001). Moreover, LUNX gene is exclusively expressed in human lungs and can be used as an efficient marker in body fluids or tissues for detection of patients with NSCLC (Karimi et al., 2015). The exact mechanism of action of this gene is not clear; however, it may play a role in innate immunity (Karimi et al., 2015). Thus, its assessment may be helpful for detection of NSCLC (Karimi et al., 2015).

This study aimed to assess P16, CDH1 and LUNX genes expression level in black anthracotic lesions and adjacent healthy tissues to evaluate the correlation of anthracosis with NSCLC.

Materials and Methods {#sec1-2}
=====================

This study was approved by the ethics committee of Masih Daneshvari Hopsital, affiliated to Shahid Beheshti University of Medical Sciences. After obtaining ethical code to No.IR.SBMU.NRITLD.REC.1394.137, forty anthracotic patients were selected and enrolled after signing written informed consent forms. Tissue samples were obtained from the center and margins of anthracotic lesions. Biopsy samples were transferred to a laboratory and subjected to RNA extraction using Cinna Pure RNA kit (Cat No: PR891620-S). First, 20-25 mg of the fresh tissue was milled; 400 μL of the lysis solution present in the kit was added to the milled tissue, mixed and homogenized. The precipitation solution was added to the homogenized mixture and the obtained solution was transferred to the extraction column and centrifuged. washing buffers were poured on the column and centrifuged. Eventually, 50 μL of RNase free water was poured on the column and pure RNA present in the column was extracted. The quality of RNA was then assessed by NanoDrop. In the next step, cDNA was synthesized using Viva 2-step RT-PCR (Cat No. RTPL12); 15μL of RNA obtained according to the instructions provided in the kit was used for cDNA synthesis. Each RNA sample was used for cDNA synthesis three times and three cDNA vials were synthesized and controlled with NanoDrop. Primers were obtained using allele ID7 software, controlled and synthesized. Sequences of primers for the real-time RT-PCR reaction are shown in [Table 1](#T1){ref-type="table"}.

###### 

Primers and Their Sequences for the Real-Time RT-PCR Reaction

                   Gene                                                                           
  ---------------- ----------------------- ------------------------------- ---------------------- ----------------------
  Forward primer   ACCCTGGATGTCCTCTATGG    TGCCATAGATGAATTGAAGGAATG        CCACCGTCTCTATGTCACCA   GTAACCCGTTGAACCCCATT
  Primer length    20                      24                              20                     20
  Reverse primer   CAGGCATAGGTCCCGTTATTA   TGTCATATATTAATTGCATAAACACCTCA   GCCAAGTCCATCAAGCAGA    CCATCCAATCGGTAGTAGCG
  Primer length    21                      29                              19                     20

Real-time RT-PCR {#sec2-1}
----------------

Real-time RT-PCR was carried out using Hot Tag EvaGreen q PCR Mix kit. The cDNA aliquots were then utilized in qPCR reactions for P16, CDH1 and LUXN genes, with 18s rRNA used as the endogenous reference gene. The reaction components were template (2μL), master mix (4μL) and F and R primers (0.5μL). The final volume was reached to 20μl by deionized distilled water. The positive and negative controls were also used.

Statistical analysis {#sec2-2}
--------------------

The data were statistically analyzed using SPSS version 20 and analyzed using t-test followed by Bonferroni's post-hoc test. The differences were considered significant when the P-values were lower than 0.001.

Results {#sec1-3}
=======

A total of 40 patients with mean age of 49±10 years were evaluated (six females and 34 males).18s rRNA gene was chosen as the reference gene. Comparison of the mean Ct values of the samples obtained from the center and margins of the lesions showed non-significant difference (P=0.234), indicating that selection of this gene as the reference gene was appropriate selection.

Expression of P16, CDH1 and LUNX genes was positive at the center of lesions in nine out of 40 (22.5%), 18 out of 40 (45%) and 19 out of 40 (47.5%) patients, respectively. Expression of P16, CDH1 and LUNX genes was positive at the margins of lesions in 25 out of 40 (62.5%), 27 out of 40 (67.5%) and six out of 40 (15%) patients, respectively. Comparison of the rate of positivity of P16 CDH1 and LUNX genes at the center and margins of lesions showed a significant difference (P\<0.001) ([Figure 1](#F1){ref-type="fig"}).

![Evaluation of CDH1, LUXN and P16 mRNA Expression in the Center and Borders of the Lesions by RT PCR](APJCP-18-3129-g001){#F1}

To increase sensitivity, all tests were performed in triplicate to obtain more accurate results.

Difference in expression level of P16, CDH1 and LUNX genes at the center and borders of lesions {#sec2-3}
-----------------------------------------------------------------------------------------------

The obtained value for P16 was 1.51, which indicated that the number of primary transcripts of this marker at the center of lesions was 1.51 times lower than the rate at the margins. The obtained value for CDH1 was 1.23, which indicated that the number of primary transcripts of this marker at the center of lesions was 1.23 times lower than the rate at the margins. This value for LUNX was 2.92; indicating that the primary transcripts for this marker at the center of lesions were 2.92 times higher than those at the margins ([Figure 2](#F2){ref-type="fig"}).
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Discussion {#sec1-4}
==========

Anthracosis refers to accumulation of coal particles and their black pigments (mainly composed of carbon) in the lungs. These black pigments are also found in the form of black lesions in the bronchi of coal miners, workers in some specific industries and those living in metropolitan areas (Castranova et al., 2002; Searl et al., 2002).

Although anthracosis is a simple indicator of air pollution or smoking, accurate estimation of the amount of deposited particles is difficult (Seto et al., 1994). Thus, in general, inhalation of carbon particles present in polluted air of cities or direct exposure to smoke in workplaces may result in anthracosis (Seto et al., 1994; Konno et al., 2004)

Previous studies have shown a correlation between anthracosis and clinical characteristics of pulmonary adenocarcinoma (Hou et al., 1998; Konno et al., 2004). DNA methylation at the promoter plays an important role in development of cancer and tumor growth via the expression of some specific genes (Konno et al., 2004). However, methylation is not always seen in a specific type of cancer but it occurs in specific tissues (Konno et al., 2004).

This study sought to assess the correlation between black anthracotic lesions and NSCLC. Thus, three genes with changed expression in cancer were chosen. Based on previous studies, LUNX gene, which is an exclusive gene in NSCLC was chosen to better elucidate this correlation (Karimi et al., 2015). Expression of this gene at the center and margins of lesions was detected using real-time RT-PCR, which is accurate and sensitive technique and is commonly used for assessment of expression of genes and biomarkers (Karimi et al., 2015; Mohamadnia et al., 2016; Bahrami et al., 2016). Genes evaluated in this study were P16, CDH1 and LUNX. First, tissue samples were taken from patients, total RNA was extracted, and cDNA was synthesized and assessed by real-time RT-PCR. All tests were done in triplicate to increase sensitivity and specificity (Castaldo et al., 1997; Sun et al., 2007).

P16 protein in most cancers undergoes genetic changes such as mutation and hyper methylation of promoter, causing a reduction in expression of P16 protein and uncontrolled growth, eventually enhancing the occurrence of cancer (Shima et al., 2011). Our findings indicated a significant reduction in expression of P16 gene at the center of anthracotic lesions compared to the margins. In line with our findings, previous studies have demonstrated a down regulation of P16 in cancerous tissues compared to adjacent healthy tissues (Tada et al., 2002).

It has also been reported a reduction in expression of P16 gene in 38% of the patients with colorectal cancer (Zou et al., 2002). The findings of research also have demonstrated lymph node metastasis in tumors with decreased expression of P16 (Tada et al., 2002).

CDH1 molecules are adhesion molecules that regulate cell cycle and interactions with other cells. They also play a role in tumor invasion and metastasis (Waki et al., 2003). In our study, it was revealed that expression level of CDH1 gene significantly decreased at the center of lesions compared to the margins. Reduction in expression of CDH1 (e-cadherin) was also observed in cell lines causing invasion and metastasis (Cano et al., 2000). Evaluation of breast cancers has demonstrated that the expression of CDH1 was significantly lower on the surface of cancer cells (Kashiwagi et al., 2010), a finding which was closely in accordance with our findings.

In the present study, we have shown increased expression level of LUNX gene at the center of lesions compared to the margins. The previous studies have shown that LUNX gene was up regulated in NSCLC patients compared to healthy individuals (Iwao et al., 2001). It has also been emphasized that LUNX gene is a specific marker for lung cancer (Karimi et al., 2015), confirming our results.

In conclusion, decreased expression of P16 and CDH1 and increased expression of LUNX tumor genes were noted at the center of anthracotic lesions. Significant increase in expression of LUNX gene in NSCLC indicates an association between anthracosis and NSCLC, according to which, anthracotic patients may carry a high risk for NSCLC.
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